AFP Trends Predict Outcomes in Liver Cancer
In a breakthrough study poised to reshape therapeutic strategies for unresectable hepatocellular carcinoma (uHCC), researchers have identified distinct patterns in the behavior of alpha-fetoprotein (AFP) levels that independently predict patient outcomes under lenvatinib treatment. Hepatocellular carcinoma, a primary malignancy of the liver, presents significant clinical challenges when surgical resection is no longer an option. The […]
In a breakthrough study poised to reshape therapeutic strategies for unresectable hepatocellular carcinoma (uHCC), researchers have identified distinct patterns in the behavior of alpha-fetoprotein (AFP) levels that independently predict patient outcomes under lenvatinib treatment. Hepatocellular carcinoma, a primary malignancy of the liver, presents significant clinical challenges when surgical resection is no longer an option. The […]
What's Your Reaction?
